Rick Winningham | Chief Executive Officer |
Rhonda Farnum | Chief Business Officer |
Rick Graham | Senior Vice President of Research and Development |
Aziz Sawaf | Chief Financial Officer |
David Risinger | SVB Securities |
Jingming Chen | Evercore |
Divya Rao | TD Cowen |
Ladies and gentlemen, good afternoon. I’d like to welcome everyone to the Theravance Biopharma First Quarter 2023 Conference Call. [Operator Instructions] Also, today’s conference call is being recorded.
And now I’d like to turn the call over to Rick Winningham, Chief Executive Officer. Please go ahead.